Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 3 | |
Outperform | 4 | |
Hold | 5 | |
Sell | 2 | |
Strong Sell | 1 |
Share price forecast in USD
The 13 analysts offering 12 month price targets for PTC Therapeutics, Inc. have a median target of 33.00, with a high estimate of 64.00 and a low estimate of 26.00. The median estimate represents a -8.74% decrease from the last price of 36.16.
High | 77.0% | 64.00 |
Med | -8.7% | 33.00 |
Low | -28.1% | 26.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Oct 24, 2024.
Average growth rate | +12.76% |
Average growth rate | -19.92% |
More ▼
Revenue history & estimates in USD
Average growth rate | +1.36% |
Average growth rate | +32.36% |
More ▼